PharmaBXL
The computed 12-month bankruptcy probability of PharmaBXL is 1.7% (average). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 3 yrs |
| Board | 2 |
| Locations | 1 |
| Publications | 9 |
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 30-09-2025 | 2025-00526921 |
| 31-12-2023 | verkort | 26-08-2024 | 2024-00372308 |
-
PharmaLegalLegal entityManaging director· perm. rep.: Georges DE FEUState Gazette act 26044294 (31-03-2026)Current13-02-2026 → present
-
Current06-02-2023 → present
Former directors (1)
-
O2CLegal entityManaging director· perm. rep.: Olivier OLBRECHTSState Gazette act 26044294 (31-03-2026)Former— → 13-02-2026
| NACE primary | 82990 |
| Legal form | Private limited company(610) |
| Incorporation | 29-12-2022 |
| Status | Active |
| Postal code | 1082 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21342B0108/00W005 | Brussels | 300 m² | 1 · 152 m² | 14.7 m · 4 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
31-03-2026 1 director appointed, 1 resigning
- PharmaLegal — Gedelegeerd bestuurder
- Olivier OLBRECHTS — Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Olivier OLBRECHTS",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0541.432.719",
"name": "PharmaLegal",
"address": "Besmelaan 103, 1190 Vorst",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-03-31",
"filing_date": "2026-03-24",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "raad_van_bestuur",
"date": "2026-02-13",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PharmaBXL",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0541.432.719",
"org_name": "BV PharmaLegal",
"person_name": null,
"org_rep_person_name": "Georges De Feu",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}31-03-2026 1 director appointed, 1 resigning
- Georges DE FEU — Gedelegeerd bestuurder
- Olivier OLBRECHTS — Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Olivier OLBRECHTS",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0844823280",
"name": "O2C",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2026-02-13",
"evidence_quote": "De raad van bestuur besluit om de besloten vennootschap \u0022O2C\u0022 (ondernemingsnummer 0844.823.280), vast vertegenwoordigd door de heer Olivier OLBRECHTS, met ingang van heden te ontslaan als gedelegeerd bestuurder."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Georges DE FEU",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0541432719",
"name": "PharmaLegal",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2026-02-13",
"evidence_quote": "Vervolgens besluit de raad van bestuur om - overeenkomstig artikel 11 \u00A71 van de statuten - het dagelijks bestuur van de vennootschap te delegeren aan de volgende bestuurder, die bijgevolg wordt aangesteld als gedelegeerd bestuurder: De besloten vennootschap \u0022PharmaLegal\u0022, met zetel te Besmelaan 103,"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PHARMABXL",
"legal_form": "BV"
}
}26-01-2026 Articles of association amended — translation of the articles, coordination of the articles and amendment of specific articles
Technical details
{
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-01-26",
"filing_date": "2026-01-22",
"act_kind_objet": "ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-12-30",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": "full_restatement",
"trigger": "other",
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": {
"firm_kbo": null,
"firm_name": "Be Audit",
"ibr_number": null,
"individual_name": "Ghislain DOCHEN"
},
"subject_company": {
"kbo": "0795.508.480",
"name_full_after": "PharmaBXL",
"legal_form_after": "BESloten Vennootschap",
"name_full_before": "PharmaBXL",
"current_zetel_raw": "Koekelberglaan 1, 1082 Sint-Agatha-Berchem",
"legal_form_before": "BESloten Vennootschap"
},
"special_mandates": [
{
"holder_kbo": "0544.887.107",
"holder_name": "Cercatrova",
"scope_categories": [
"kbo"
],
"with_substitution": true
},
{
"holder_kbo": null,
"holder_name": "REMEDIA",
"scope_categories": [
"kbo"
],
"with_substitution": true
},
{
"holder_kbo": "0812.730.336",
"holder_name": "DRI3M",
"scope_categories": [
"kbo"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Artikel 5 van de statuten is vervangen door nieuwe tekst die de uitgifte van nieuwe aandelen regelt, de winstverdeling en het boekhoudkundige verkeer van inbrengen in natura en in geld.",
"new_text": "Als vergoeding voor de inbrengen werden zes miljoen achthonderd negentwintig duizend honderd tachtig (6.829.180) uitgegeven. Ieder aandeel geeft een gelijk recht in de winstverdeling en in het vereffeningssaldo. De huidige inbrengen werden geboekt op een beschikbare eigen vermogensrekening. Voor de latere inbrengen zullen de uitgiftevoorwaarden bepalen of zij geboekt worden op een onbeschikbare da",
"change_kind": "replaced",
"article_title": null,
"article_number": "5"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"drie volmachten",
"een aanwezigheidslijst",
"de geco\u00F6rdineerde tekst van statuten",
"het verslag van het bestuursorgaan opgesteld in toepassing van de artikelen 5:121, \u00A71, eerste lid, 5:130 en 5:133, \u00A71, eerste lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de bedrijfsrevisor opgesteld in toepassing van artikel 5:133, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de bedrijfsrevisor opgesteld in toepassing van artikel 5:121, \u00A71, tweede lid en artikel 5:130 van het Wetboek van vennootschappen en verenigingen"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"eigen_aandelen_inkoop",
"wvv_capital_release",
"share_class_creation"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": null,
"label": "bestaande aandelen",
"rights_summary": "gelijk recht in de winstverdeling en in het vereffeningssaldo",
"voting_per_share": null
},
{
"count": null,
"label": "nieuwe aandelen",
"rights_summary": "gelijk recht in de winstverdeling en in het vereffeningssaldo",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}26-01-2026 Capital increase of €455,000
- Inbreng in geld · Apport en numéraire
- 5 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 110208,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 455000.0,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 5402453,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 455000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-01-26",
"filing_date": "2026-01-22",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-12-30",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "Be Audit",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Ghislain DOCHEN"
},
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PharmaBXL",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"drie volmachten",
"een aanwezigheidslijst",
"de geco\u00F6rdineerde tekst van statuten",
"het verslag van het bestuursorgaan opgesteld in toepassing van de artikelen 5:121, \u00A71, eerste lid, 5:130 en 5:133, \u00A71, eerste lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de bedrijfsrevisor opgesteld in toepassing van artikel 5:133, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de bedrijfsrevisor opgesteld in toepassing van artikel 5:121, \u00A71, tweede lid en artikel 5:130 van het Wetboek van vennootschappen en verenigingen"
],
"shareholders_after": [],
"share_classes_after": []
}26-01-2026 1 director appointed, 2 resigning
- MAERIEN Etienne August Caroline — Bestuurder
- VAN HAVERBEKE Charles Daniel Jozef Petrus — Vaste vertegenwoordiger
- Ravelingien — Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "VAN HAVERBEKE Charles Daniel Jozef Petrus",
"address": null,
"birth_date": "1988-11-06",
"profession": null,
"birth_place": "Turnhout"
},
"reason": "de_plein_droit_dissolution",
"subkind": "regular",
"via_org": {
"kbo": "0544.887.107",
"name": "Cercatrova",
"address": "Kammenstraat 68, 2000 Antwerpen",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende personen als bestuurder van de Vennootschap, met ingang vanaf heden: - de besloten vennootschap \u2018\u2019Cercatrova\u2019\u2019, met zetel te 2000 Antwerpen, Kammenstraat 68, en met ondernemingsnummer 0544.887.107, vast vertegenwoordigd door de",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Ravelingien",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "REMEDIA",
"address": null,
"country": null,
"legal_form": "CV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende personen als bestuurder van de Vennootschap, met ingang vanaf heden: - de besloten vennootschap \u2018\u2019Cercatrova\u2019\u2019, met zetel te 2000 Antwerpen, Kammenstraat 68, en met ondernemingsnummer 0544.887.107, vast vertegenwoordigd door de",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "MAERIEN Etienne August Caroline",
"address": null,
"birth_date": "1960-11-28",
"profession": null,
"birth_place": "Turnhout"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": "0812.730.336",
"name": "DRI3M",
"address": "Ledebergstraat 67, 9050 Gentbrugge",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen als bestuurder van de Vennootschap, vanaf heden en dit voor een onbepaalde duur: - de besloten vennootschap \u0022DRI3M\u0022, met zetel te 9050 Gentbrugge, Ledebergstraat 67 en met ondernemingsnummer 0812.730.336, vast vertegenwoordigd door de heer MAERIEN Etienne August Ca",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN HAVERBEKE Charles Daniel Jozef Petrus",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": "0544.887.107",
"name": "Cercatrova",
"address": "Kammenstraat 68, 2000 Antwerpen",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering verleent hen, voor zover als mogelijk, kwijting.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ravelingien",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "REMEDIA",
"address": null,
"country": null,
"legal_form": "CV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering verleent hen, voor zover als mogelijk, kwijting.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-01-26",
"filing_date": "2026-01-22",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-12-30",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PharmaBXL",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tim CARNEWAL",
"org_rep_person_name": null,
"person_role_at_subject": "Notaris"
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"drie volmachten",
"een aanwezigheidslijst",
"de geco\u00F6rdineerde tekst van statuten",
"het verslag van het bestuursorgaan opgesteld in toepassing van de artikelen 5:121, \u00A71, eerste lid, 5:130 en 5:133, \u00A71, eerste lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de bedrijfsrevisor opgesteld in toepassing van artikel 5:133, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"het verslag van de bedrijfsrevisor opgesteld in toepassing van artikel 5:121, \u00A71, tweede lid en artikel 5:130 van het Wetboek van vennootschappen en verenigingen"
],
"corrected_publication_numac": null
}14-03-2023 Jo Ravelingien appointed as director
- Jo Ravelingien — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jo Ravelingien",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0894633869",
"name": "Remedia",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-02-06",
"evidence_quote": "Tijdens de bijzondere algemene vergadering gehouden op het adres van de statutaire zetel op 06/02/2023 werd besloten te benoemen als bestuurder, de commanditaire vennootschap Remedia, met zetel te 1861 Meise, Brussegemsesteenweg 39, met als ondernemingsnummer 0894.633.869, vast vertegenwoordigd door"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PHARMABXL",
"legal_form": "BV"
}
}14-03-2023 Jo Ravelingien appointed as director
- Jo Ravelingien — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jo Ravelingien",
"address": "1861 Meise, Brussegemsesteenweg 39",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": "0894.633.869",
"name": "Remedia",
"address": "1861 Meise, Brussegemsesteenweg 39",
"country": "BE",
"legal_form": "CV"
},
"statutory": null,
"compensated": null,
"effective_date": "2023-02-06",
"evidence_quote": "werd besloten te benoemen als bestuurder, de commanditaire vennootschap Remedia, met zetel te 1861 Meise, Brussegemsesteenweg 39, met als ondernemingsnummer 0894.633.869, vast vertegenwoordigd door Dhr. Jo Ravelingien, wonende te 1861 Meise, Brussegemsesteenweg 39 en dit met onmiddellijke ingang van",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": null,
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2023-02-06",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PharmaBXL",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Inge Van den Broeck",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}01-02-2023 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2023-01-26",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PHARMABXL",
"legal_form": "BV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}02-01-2023 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "1082 Sint-Agatha-Berchem, Koekelberglaan 1",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1971-08-10",
"name": "BRACKE Sven Guido Diane",
"niss": null,
"address": "1780 Wemmel, de Limburg Stirumlaan 81"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 6222.2,
"holder_person_name": "BRACKE Sven Guido Diane",
"is_subscriber_only": true,
"n_shares_subscribed": 62222,
"amount_subscribed_eur": 6222.2,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1989-07-02",
"name": "DE FEU Georges Charlotte Jan Madelaine",
"niss": null,
"address": "1060 Sint-Gillis, Bosquetstraat 50 bus 0003"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 50222.2,
"holder_person_name": "DE FEU Georges Charlotte Jan Madelaine",
"is_subscriber_only": false,
"n_shares_subscribed": 502222,
"amount_subscribed_eur": 50222.2,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1973-10-25",
"name": "GILIAS Filip Maria Andre",
"niss": null,
"address": "3384 Glabbeek (Attenrode), Doemstraat 6"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 12444.4,
"holder_person_name": "GILIAS Filip Maria Andre",
"is_subscriber_only": false,
"n_shares_subscribed": 124444,
"amount_subscribed_eur": 12444.4,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1975-01-21",
"name": "OLBRECHTS Olivier Ivan Val\u00E9ry",
"niss": null,
"address": "1180 Ukkel, Prins van Oranjelaan 50"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 24888.9,
"holder_person_name": "OLBRECHTS Olivier Ivan Val\u00E9ry",
"is_subscriber_only": false,
"n_shares_subscribed": 248889,
"amount_subscribed_eur": 24888.9,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1996-10-16",
"name": "VANDENHOVE Thibault Henri Brigitte",
"niss": null,
"address": "1060 Sint-Gillis, Blanchestraat 37 GV"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 3111.1,
"holder_person_name": "VANDENHOVE Thibault Henri Brigitte",
"is_subscriber_only": true,
"n_shares_subscribed": 31111,
"amount_subscribed_eur": 3111.1,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1988-11-06",
"name": "VAN HAVERBEKE Charles Daniel Jozef Petrus",
"niss": null,
"address": "2000 Antwerpen, Kammenstraat 68 bus 301"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 3111.1,
"holder_person_name": "VAN HAVERBEKE Charles Daniel Jozef Petrus",
"is_subscriber_only": false,
"n_shares_subscribed": 31111,
"amount_subscribed_eur": 3111.1,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 10000,
"subject_company": {
"kbo": "0795.508.480",
"name_full": "PharmaBXL",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2022-12-28",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | PharmaBXL |